Biology Reference
In-Depth Information
Suvarna NU, O'Donnell JM (2002) Hydrolysis of N-methyl-D-aspartate receptor-stimulated
cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of
rat cerebral cortex and hippocampus. J Pharmacol Exp Ther 302:249-256
Takahashi M, Terwilliger R, Lane C, Mezes PS, Conti M, Duman RS (1999) Chronic antidepressant
administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B
isoforms. J Neurosci 19:610-618
Tanis KQ, Duman RS (2007) Intracellular signaling pathways pave roads to recovery for mood
disorders. Ann Med 39:531-544
Taylor JR, Birnbaum SG, Ubriani R, Arnsten AFT (1999) Activation of protein kinase A in
prefrontal cortex impairs working memory performance. J Neurosci 19:RC23
Taylor RE, Shows KH, Zhao Y, Pittler SJ (2001) A PDE6A promoter fragment directs transcrip-
tion predominantly in the photoreceptor. Biochem Biophys Res Commun 282:543-547
Teng FY, Tang BL (2006) Axonal regeneration in adult CNS neurons-signaling molecules and
pathways. J Neurochem 96:1501-1508
Thompson PE, Manganiello V, Degerman E (2007) Re-discovering PDE3 inhibitors - new
opportunities for a long neglected target. Curr Top Med Chem 7:421-436
Titus SA, Li X, Southall N, Lu J, Inglese J, BraschM, Austin CP, ZhengW (2008) A cell-based PDE4
assay in 1536-well plate format for high-throughput screening. J Biomol Screen 13:609-618
Torras-Llort M, Azorin F (2003) Functional characterization of the human phosphodiesterase 7A1
promoter. Biochem J 373:835-843
Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V,
Dhanasekaran M (2007) Versatile effects of sildenafil: recent pharmacological applications.
Pharmacol Rep 59:150-163
Valera E, S´nchez-Mart´n FJ, Ferrer-Montiel AV, Messeguer A, Merino JM (2008)
NMDA-induced neuroprotection in hippocampal neurons is mediated through the protein
kinase A and CREB (cAMP-response element-binding protein) pathway. Neurochem Int 58:
148-154
Van der Staay FJ, Rutten K, B
arfacker L, Devry J, Erb C, Heckroth H, Karthaus D, Tersteegen A,
van Kampen M, Blokland A, Prickaerts J, Reymann KG, Schr
€
oder UH, Hendrix M (2008) The
novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents.
Neuropharmacology 55:908-918
van Donkelaar EL, Rutten K, Blokland A, Akkerman S, Steinbusch HW, Prickaerts J (2008)
Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute
tryptophan depletion. Eur J Pharmacol 600:98-104
Van Staveren WCG, Markerink-Van Ittersum M, Steinbusch HWM, De Vente J (2001) The
effect of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the
hippocampus of the rat. Brain Res 888:275-286
Van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Repaske DR, Goy MF, Kotera J,
Omori K, Beavo JA, De Vente J (2003) mRNA expression patterns of the cGMP-hydrolyzing
phosphodiester- ases types 2, 5, and 9 during development of the rat brain. J Comp Neurol
467:566-580
Vecsey CG, Baillie GS, Jaganath D, Havekes R, Daniels A, Wimmer M, Huang T, Brown KM,
Li XY, Descalzi G, Kim SS, Chen T, Shang YZ, Zhuo M, Houslay MD, Abel T (2009) Sleep
deprivation impairs cAMP signalling in the hippocampus. Nature 461:1122-1125
Viana RJ, Fonseca MB, Ramalho RM, Nunes AF, Rodrigues CM (2010) Organelle stress
sensors and cell death mechanisms in neurodegenerative diseases. CNS Neurol Disord Drug
Targets 9(6):679-692
Wachtel H (1982) Characteristic behavioural alterations in rats induced by rolipram and
other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors. Psycho-
pharmacol (Berl) 77:309-316
Weeks JL, Zoraghi R, Francis SH, Corbin JD (2007) N-Terminal domain of phosphodiesterase-
11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is
involved in oligomerization. Biochemistry 46:10353-10364
€
